The IL-8 analyses were thus also corrected for age in addition to gender in ANCOVA, but there were no statistically significant differences in IL-8 levels between the C9orf72 HRE genotypes or clinical subgroups (such as FTLD Parkinsonism vs. non-Parkinsonism). This evidence concerns the gene CXCL8 and Parkinson disease.